Investigating the Potential of Conjugated Selenium Redox Folic Acid as a Treatment for Triple Negative Breast Cancer

Previous studies have demonstrated that redox selenium compounds arrest cancer cell viability in vitro through their pro-oxidative activity by generating superoxide (O(2)(•−)). Currently, there are no efficacious treatment options for women with Triple Negative Breast Cancer (TNBC). However, the ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Khandelwal, Soni, Boylan, Mallory, Kirsch, Gilbert, Spallholz, Julian E., Gollahon, Lauren S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071027/
https://www.ncbi.nlm.nih.gov/pubmed/32033374
http://dx.doi.org/10.3390/antiox9020138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071027/
https://www.ncbi.nlm.nih.gov/pubmed/32033374
http://dx.doi.org/10.3390/antiox9020138

Ejemplares similares